Vir Biotechnology, Inc. Quarterly Depreciation in USD from Q1 2023 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Vir Biotechnology, Inc. quarterly Depreciation history and growth rate from Q1 2023 to Q3 2024.
  • Vir Biotechnology, Inc. Depreciation for the quarter ending September 30, 2024 was $2.9M, a 35.6% decline year-over-year.
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $2.9M -$1.6M -35.6% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-04
Q2 2024 $4.2M -$400K -8.7% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $4.4M -$1.1M -20% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-03
Q3 2023 $4.5M Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-04
Q2 2023 $4.6M Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $5.5M Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-03
* An asterisk sign (*) next to the value indicates that the value is likely invalid.